annual CFI:
$165.00M+$276.38M(+248.13%)Summary
- As of today (September 10, 2025), XENE annual cash flow from investing activities is $165.00 million, with the most recent change of +$276.38 million (+248.13%) on December 31, 2024.
- During the last 3 years, XENE annual CFI has risen by +$411.77 million (+166.86%).
- XENE annual CFI is now at all-time high.
Performance
XENE Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$84.39M+$49.88M(+144.54%)Summary
- As of today (September 10, 2025), XENE quarterly cash flow from investing activities is $84.39 million, with the most recent change of +$49.88 million (+144.54%) on June 1, 2025.
- Over the past year, XENE quarterly CFI has dropped by -$24.33 million (-22.38%).
- XENE quarterly CFI is now -22.38% below its all-time high of $108.72 million, reached on June 30, 2024.
Performance
XENE quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$216.48M-$24.33M(-10.10%)Summary
- As of today (September 10, 2025), XENE TTM cash flow from investing activities is $216.48 million, with the most recent change of -$24.33 million (-10.10%) on June 1, 2025.
- Over the past year, XENE TTM CFI has increased by +$341.85 million (+272.68%).
- XENE TTM CFI is now -10.10% below its all-time high of $240.81 million, reached on March 31, 2025.
Performance
XENE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
XENE Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +248.1% | -22.4% | +272.7% |
| 3 y3 years | +166.9% | +5493.7% | +188.3% |
| 5 y5 years | +349.2% | +630.9% | +329.6% |
XENE Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.2% | -22.4% | +135.3% | -10.1% | +144.1% |
| 5 y | 5-year | at high | +156.2% | -22.4% | +135.3% | -10.1% | +144.1% |
| alltime | all time | at high | +156.2% | -22.4% | +135.3% | -10.1% | +144.1% |
XENE Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $84.39M(+144.5%) | $216.48M(-10.1%) |
| Mar 2025 | - | $34.51M(-63.8%) | $240.81M(+47.6%) |
| Dec 2024 | $165.00M(-248.1%) | $95.40M(+4281.2%) | $163.11M(-195.1%) |
| Sep 2024 | - | $2.18M(-98.0%) | -$171.47M(+36.8%) |
| Jun 2024 | - | $108.72M(-351.7%) | -$125.37M(-39.1%) |
| Mar 2024 | - | -$43.19M(-81.9%) | -$205.92M(+77.4%) |
| Dec 2023 | -$111.39M(-62.0%) | -$239.18M(-595.4%) | -$116.11M(-200.2%) |
| Sep 2023 | - | $48.28M(+71.4%) | $115.91M(-171.7%) |
| Jun 2023 | - | $28.17M(-39.6%) | -$161.68M(-14.2%) |
| Mar 2023 | - | $46.62M(-750.6%) | -$188.34M(-33.6%) |
| Dec 2022 | -$293.40M(+18.9%) | -$7.17M(-96.9%) | -$283.85M(-42.2%) |
| Sep 2022 | - | -$229.30M(<-9900.0%) | -$490.91M(+100.2%) |
| Jun 2022 | - | $1.51M(-103.1%) | -$245.16M(+2.5%) |
| Mar 2022 | - | -$48.89M(-77.2%) | -$239.21M(-2.5%) |
| Dec 2021 | -$246.77M(+1366.8%) | -$214.23M(-1402.8%) | -$245.43M(-2092.4%) |
| Sep 2021 | - | $16.44M(+120.3%) | $12.32M(-152.2%) |
| Jun 2021 | - | $7.46M(-113.5%) | -$23.58M(+20.9%) |
| Mar 2021 | - | -$55.10M(-226.6%) | -$19.50M(+12.6%) |
| Dec 2020 | -$16.82M(-74.6%) | $43.52M(-323.7%) | -$17.32M(-85.7%) |
| Sep 2020 | - | -$19.45M(-268.5%) | -$121.40M(+28.8%) |
| Jun 2020 | - | $11.55M(-121.8%) | -$94.28M(-16.2%) |
| Mar 2020 | - | -$52.92M(-12.6%) | -$112.53M(+68.9%) |
| Dec 2019 | -$66.21M | -$60.57M(-890.7%) | -$66.64M(+263.3%) |
| Sep 2019 | - | $7.66M(-214.4%) | -$18.34M(-62.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$6.70M(-4.7%) | -$49.03M(+21.2%) |
| Mar 2019 | - | -$7.03M(-42.7%) | -$40.46M(+42.2%) |
| Dec 2018 | -$28.99M(-219.3%) | -$12.27M(-46.7%) | -$28.45M(+166.1%) |
| Sep 2018 | - | -$23.03M(-1331.0%) | -$10.69M(-180.9%) |
| Jun 2018 | - | $1.87M(-62.4%) | $13.22M(-35.6%) |
| Mar 2018 | - | $4.98M(-9.3%) | $20.53M(-17.2%) |
| Dec 2017 | $24.29M(-150.8%) | $5.49M(+519.3%) | $24.80M(-301.7%) |
| Sep 2017 | - | $885.70K(-90.4%) | -$12.30M(-5.9%) |
| Jun 2017 | - | $9.19M(-0.7%) | -$13.06M(-65.8%) |
| Mar 2017 | - | $9.25M(-129.2%) | -$38.17M(-19.6%) |
| Dec 2016 | -$47.84M(-569.3%) | -$31.62M(<-9900.0%) | -$47.50M(+197.1%) |
| Sep 2016 | - | $121.40K(-100.8%) | -$15.99M(+103.0%) |
| Jun 2016 | - | -$15.92M(>+9900.0%) | -$7.87M(-196.1%) |
| Mar 2016 | - | -$83.00K(-20.3%) | $8.19M(-16.1%) |
| Dec 2015 | $10.19M(-414.2%) | -$104.20K(-101.3%) | $9.77M(-11.3%) |
| Sep 2015 | - | $8.24M(+5599.4%) | $11.01M(-516.4%) |
| Jun 2015 | - | $144.50K(-90.3%) | -$2.64M(+99.4%) |
| Mar 2015 | - | $1.49M(+30.8%) | -$1.33M(-58.0%) |
| Dec 2014 | -$3.24M(-71.7%) | $1.14M(-121.0%) | -$3.15M(-26.5%) |
| Sep 2014 | - | -$5.42M(-470.4%) | -$4.29M(-481.7%) |
| Jun 2014 | - | $1.46M(-532.8%) | $1.13M(-432.8%) |
| Mar 2014 | - | -$338.00K | -$338.00K |
| Dec 2013 | -$11.47M(-2436.5%) | - | - |
| Dec 2012 | $491.00K(-96.5%) | - | - |
| Dec 2011 | $13.89M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual CFI year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly CFI year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM CFI year-on-year change?
What is Xenon Pharmaceuticals Inc. annual cash flow from investing activities?
The current annual CFI of XENE is $165.00M
What is the all time high annual CFI for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual cash flow from investing activities is $165.00M
What is Xenon Pharmaceuticals Inc. annual CFI year-on-year change?
Over the past year, XENE annual cash flow from investing activities has changed by +$276.38M (+248.13%)
What is Xenon Pharmaceuticals Inc. quarterly cash flow from investing activities?
The current quarterly CFI of XENE is $84.39M
What is the all time high quarterly CFI for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly cash flow from investing activities is $108.72M
What is Xenon Pharmaceuticals Inc. quarterly CFI year-on-year change?
Over the past year, XENE quarterly cash flow from investing activities has changed by -$24.33M (-22.38%)
What is Xenon Pharmaceuticals Inc. TTM cash flow from investing activities?
The current TTM CFI of XENE is $216.48M
What is the all time high TTM CFI for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM cash flow from investing activities is $240.81M
What is Xenon Pharmaceuticals Inc. TTM CFI year-on-year change?
Over the past year, XENE TTM cash flow from investing activities has changed by +$341.85M (+272.68%)